CytoMed logo.png
CytoMed Therapeutics Limited Announces Research Collaboration with Singapore Sengkang General Hospital to Advance Injectable Umbilical Cord-Derived Mesenchymal Stem Cells for Cartilage Diseases and Repair
March 04, 2024 05:00 ET | CYTOMED THERAPEUTICS LIMITED
SINGAPORE, March 04, 2024 (GLOBE NEWSWIRE) -- CytoMed Therapeutics Limited (NASDAQ: GDTC) (“CytoMed” or “Company”), a Singapore-based biopharmaceutical company focused on harnessing its proprietary...
S+N Logo.jpg
Smith+Nephew unveils expanded Sports Medicine portfolio to enable biological healing at AAOS 2024 Annual Meeting
February 12, 2024 08:00 ET | Smith & Nephew UK Ltd
12 February 2024 Smith+Nephew (LSE:SN, NYSE:SNN), the global medical technology company, announces the premiere of its newly acquired CARTIHEAL◊ AGILI-C◊ Cartilage Repair Implant alongside the...
22157.jpg
Orthopedic Devices Sector Forecast: In-Depth Analysis of the Cartilage Repair Market Growth, Regulatory Framework, and Projections Through 2033
January 22, 2024 09:23 ET | Research and Markets
Dublin, Jan. 22, 2024 (GLOBE NEWSWIRE) -- The "Cartilage Repair Market Size by Segments, Share, Regulatory, Reimbursement, Procedures and Forecast to 2033" report has been added to ...
Global Cartilage Repair/Cartilage Regeneration Market
Global Cartilage Repair/Cartilage Regeneration Market Forecasts to 2028 - Rising Number of Sports and Accident-Related Orthopedic Injuries
January 08, 2024 05:33 ET | Research and Markets
Dublin, Jan. 08, 2024 (GLOBE NEWSWIRE) -- The "Global Cartilage Repair/Cartilage Regeneration Market by Treatment Modalities (Cell-Based (Chondrocyte Transplantation, Stem Cells, Growth Factors),...
RationalStat Logo 1.png
RationalStat New Report Analyzes the Cartilage Repair and Cartilage Regeneration Market and Competition Landscape
November 03, 2023 03:05 ET | Rationalstat LLC
Wilmington, Delaware, Nov. 03, 2023 (GLOBE NEWSWIRE) -- Global Cartilage Repair and Cartilage Regeneration Market value is estimated at US$ 1.4 billion in 2023 and is expected to grow at a...
Global Market for Cartilage Repair / Cartilage Regeneration
Cartilage Repair/Cartilage Regeneration Global Market to Reach $2.7 Billion by 2030: Increasing Incidences of Sports-related Injuries Drives Demand
May 15, 2023 10:18 ET | Research and Markets
Dublin, May 15, 2023 (GLOBE NEWSWIRE) -- The "Cartilage Repair / Cartilage Regeneration - Global Strategic Business Report" report has been added to ResearchAndMarkets.com's offering. The global...
22157.jpg
$3.5 Billion Worldwide Knee Cartilage Repair Industry to 2027 - Impact of COVID-19 on the Market
December 16, 2020 04:33 ET | Research and Markets
Dublin, Dec. 16, 2020 (GLOBE NEWSWIRE) -- The "Knee Cartilage Repair - Global Market Trajectory & Analytics" report has been added to ResearchAndMarkets.com's offering. The publisher brings...
Histogenics logo
Histogenics and FDA Continue to Discuss NeoCart® Phase 3 Clinical Trial Data and Potential Regulatory Pathway
November 29, 2018 08:30 ET | Histogenics Corporation
WALTHAM, Mass., Nov. 29, 2018 (GLOBE NEWSWIRE) -- Histogenics Corporation (Histogenics) (Nasdaq: HSGX), a leader in the development of restorative cell therapies that may offer rapid-onset pain...
Histogenics logo
Histogenics Corporation Announces Third Quarter 2018 Financial and Operating Results
November 08, 2018 06:30 ET | Histogenics Corporation
WALTHAM, Mass., Nov. 08, 2018 (GLOBE NEWSWIRE) -- ‒ Histogenics and FDA Continue Discussions on NeoCart® Phase 3 Data and Potential BLA Submission ‒‒ October 2018 Financing Expected to...
Histogenics logo
Histogenics and FDA to Continue Discussions on NeoCart Phase 3 Clinical Trial Data and Potential Regulatory Pathway
November 01, 2018 16:05 ET | Histogenics Corporation
WALTHAM, Mass., Nov. 01, 2018 (GLOBE NEWSWIRE) -- Histogenics Corporation (Histogenics) (Nasdaq: HSGX), a leader in the development of restorative cell therapies that may offer rapid-onset pain...